Related Experiment Video
Updated: May 10, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Latent transforming growth factor β-binding protein 4 is downregulated in esophageal cancer via promoter methylation
Insa Bultmann1, Anne Conradi, Celine Kretschmer
1Center for Experimental Medicine, Medical Faculty, University of Cologne, Cologne, Germany.
Abstract:
Latent transforming growth factor β-binding protein 4 (LTBP4) is an extracellular matrix molecule that is a member of important connective tissue networks and is needed for the correct folding and the secretion of TGF-β1. LTBP4 is downregulated in carcinomas of various tissues. Here we show that LTBP4 is also downregulated in adenocarcinomas and squamous cell carcinomas of the esophagus in vitro and in vivo. Re-expression of LTBP4 in esophageal cancer cell lines reduced cell migration ability, whereas cell viability and cell proliferation remained unchanged. Hypermethylation of the promoter regions of the two main human LTBP4 transcriptional forms, LTBP4L and LTBP4S, was found to be involved in LTBP4 silencing. Detailed investigations of the methylation patterns of the promoter regions of LTBP4L and LTBP4S identified GATA1, SP1, E2F4 and SMAD3 as potential transcription factors involved in LTBP4 expression. In in vitro transcription factor activity studies we discovered E2F4 as novel powerful regulator for LTBP4S expression.
Insights
Latent transforming growth factor β-binding protein 4 (LTBP4) is downregulated in esophageal cancers. Re-expressing LTBP4 reduces cancer cell migration, with hypermethylation identified as a key silencing mechanism.
Area of Science:
- Molecular Biology
- Cancer Research
- Extracellular Matrix Biology
Background:
- Latent transforming growth factor β-binding protein 4 (LTBP4) is crucial for TGF-β1 regulation and connective tissue integrity.
- LTBP4 downregulation is observed in various carcinomas, suggesting a role in tumorigenesis.
Purpose of the Study:
- To investigate the role of LTBP4 in esophageal cancer.
- To elucidate the mechanisms underlying LTBP4 downregulation in esophageal tumors.
Main Methods:
- Analysis of LTBP4 expression in esophageal cancer cell lines and tissues (in vitro and in vivo).
- Assessment of cell migration, viability, and proliferation upon LTBP4 re-expression.
- Investigation of promoter methylation patterns and transcription factor binding sites for LTBP4.
Main Results:
- LTBP4 is significantly downregulated in esophageal adenocarcinomas and squamous cell carcinomas.
- Re-expression of LTBP4 suppressed esophageal cancer cell migration but did not affect viability or proliferation.
- Hypermethylation of LTBP4 promoter regions (LTBP4L and LTBP4S) was identified as a mechanism for LTBP4 silencing.
- E2F4 was identified as a novel, potent regulator of LTBP4S expression.
Conclusions:
- LTBP4 plays a role in suppressing esophageal cancer cell migration.
- Epigenetic silencing via promoter hypermethylation contributes to LTBP4 loss in esophageal cancer.
- E2F4 emerges as a key transcription factor regulating LTBP4 expression.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation
TGF - β Signaling Pathway
Cell Specific Gene Expression
